狼疮性肾炎何时以及如何停用治疗:叙述性综述
本文综述了狼疮性肾炎和SLE中停用糖皮质激素及其他免疫抑制剂的尝试。数据显示,在长期治疗后达到完全临床缓解的患者中停药可行,需缓慢逐渐减量并在医疗监测下进行;停药后约四分之一患者可能出现肾脏或全身 flare,但多数及时诊断后可缓解,部分患者可维持缓解长达20年或更久。抗疟药有助于维持停药后的缓解,重复肾活检可能有助于决策但非必需。
要点
- 长期治疗后达到完全临床缓解的狼疮性肾炎患者可考虑停用免疫抑制治疗。
- 停药需缓慢逐渐减量并在医疗监测下进行,以预防疾病活动 flare。
核心结论
- 在长期治疗后达到完全临床缓解的狼疮性肾炎患者中,停用糖皮质激素和其他免疫抑制剂是可行的。
- 停药需缓慢逐渐减量并在医疗监测下进行,以预防疾病活动 flare。
研究设计与样本
- 叙述性综述,汇总尝试在狼疮性肾炎和SLE中停用糖皮质激素及其他免疫抑制剂的现有数据。
主要发现
- 停药后约四分之一患者可能出现肾脏或全身 flare。
- 多数 flare 若快速诊断可对治疗有反应。
- 其他患者可进入稳定缓解长达20年或更久。
- 抗疟药的使用有助于在停用免疫抑制治疗后维持缓解。
关键数值与推荐
- 部分患者可维持稳定缓解20年或更久。
临床怎么用
- 对长期治疗后达到完全临床缓解的狼疮性肾炎患者可考虑停药。
- 停药应在医疗监测下缓慢逐渐减量。
- 抗疟药可用于维持停药后的缓解。
- 重复肾活检可能有助于决定停药,但现有数据有限,不能视为必需。
局限性
- 重复肾活检用于指导停药决策的可用数据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Glucocorticoids and other immunosuppressants still represent the cornerstone drugs for the management of SLE and lupus nephritis. The refined use of these drugs over the years has allowed us to obtain stable disease remission and improvement of long-term kidney and patient survival. Nevertheless, a prolonged use of immunosuppressive agents may be accompanied by severe and even life-threatening side effects. Theoretically, a transient or even definitive withdrawal of immunosuppression could be useful to prevent iatrogenic morbidities. For many years, however, the risk of SLE reactivation has held clinicians back from trying to interrupt therapy. In this review, we report the results of the attempts to interrupt glucocorticoids and other immunosuppressive agents in lupus nephritis and in SLE. The available data suggest that therapy withdrawal is feasible at least in patients enjoying a complete clinical remission after a prolonged therapy. A slow and gradual reduction of treatment under medical surveillance is needed to prevent flares of activity. After therapy withdrawal, around one-quarter of patients may have kidney or systemic flares. However, most flares may respond to therapy if rapidly diagnosed. The other patients can enter stable remission for even 20 years or more. The use of antimalarials can help in maintaining the remission after the withdrawal of the immunosuppressive therapy. A repeated kidney biopsy could be of help in deciding to stop therapy, but given the few available data, it cannot be considered essential.
引用
- Moroni G, Frontini G, Ponticelli C, et al. When and How Is It Possible to Stop Therapy in Patients with Lupus Nephritis: A Narrative Review. Clin J Am Soc Nephrol. 2021. PMID: 34162696. doi:10.2215/CJN.04830421
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。